New hope: boosting chemo with immune drug before breast cancer surgery
NCT ID NCT04243616
Summary
This study is testing if adding an immunotherapy drug called cemiplimab to standard chemotherapy before surgery works better for certain high-risk breast cancers. It will involve 36 women with locally advanced breast cancer that tests positive for specific markers. The main goal is to see if this combination helps eliminate more cancer from the breast and lymph nodes by the time of surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INVASIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Froedtert Hospital & Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
Conditions
Explore the condition pages connected to this study.